CDX Models Help Bring Personalized Treatment for SCLC a Step Closer

Preconditioning Program Shortens Postsurgical Hospital Stay for People with Lung Cancer

Introducing the New ILCN

In Brief for February 9, 2022

In Brief for February 23, 2022

Low-Dose CT, ctDNA May Partner for Lung Cancer Detection

Award Lecture Highlights Tumor Evolution Through Liquid Biopsy

IASLC’s Global Reach a Strength on the Road to a Cure for Lung Cancer

IASLC Releases Position Statement on Air Pollution on Earth Day

IASLC Responds to Call for Evidence

Panel Explores Emerging Treatments and Sequencing Strategies for Patients with Advanced NSCLCs Driven by Rare Oncogenes

Evidence Supports Adding Biological, Pathological, and Molecular Assessments to the TNM Lung Cancer Staging System